Home › Funds › Evelyn Partners Group Ltd › APH
Evelyn Partners Group Ltd position in APH
AMPHENOL CORP · Technology
Evelyn Partners Group Ltd reported holding 886,047 shares of APH (AMPHENOL CORP) in its Q3 2026 13F filing — a position valued at US$74.7M, representing 1.19% of its reported portfolio and ranking #21 among its reported holdings. Evelyn Partners Group Ltd has disclosed APH holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-10 · Source: SEC EDGAR Form 13F-HR
How Evelyn Partners Group Ltd's APH position evolved
Evelyn Partners Group Ltd first disclosed a stake in APH in Q2 2026 at 365,938 shares (US$64.5M). The position peaked in Q3 2026 at 886,047 shares, worth US$74.7M. Across 2 filings, Evelyn Partners Group Ltd increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 886,047 shares valued at US$74.7M — an increase of 520,109 shares quarter over quarter.. Notable position changes include a 142% increase in Q3 2026 (shares fell 4% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 365.94K | $64.52M | New |
| Q3 2026 | 886.05K | $74.69M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About APH and 13F data
APH (AMPHENOL CORP) is a Technology company. 50 other funds we track also report a position in APH — the largest reported positions include BlackRock Inc (US$17.85B), Fidelity Management & Research (FMR) (US$12.44B), Capital International Investors (US$7.59B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding APH
- BlackRock Inc 101.25M sh · $17.85B · Q2 2026
- Fidelity Management & Research (FMR) 70.57M sh · $12.44B · Q2 2026
- Capital International Investors 43.04M sh · $7.59B · Q2 2026
- JPMorgan Chase & Co 39.20M sh · $6.52B · Q2 2026
- VANGUARD PORTFOLIO MANAGEMENT LLC 35.69M sh · $6.29B · Q2 2026
- PRICE T ROWE ASSOCIATES INC /MD/ 32.01M sh · $5.64B · Q2 2026
- Capital Research Global Investors 29.49M sh · $5.20B · Q2 2026
- Capital Research Global Investors 29.49M sh · $5.20B · Q2 2026
- Wellington Management Group 16.58M sh · $2.92B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 16.58M sh · $2.92B · Q2 2026
- BNY Mellon 14.57M sh · $2.57B · Q2 2026
- Arrowstreet Capital 11.89M sh · $2.10B · Q2 2026
More on Evelyn Partners Group Ltd
FAQ
How long has Evelyn Partners Group Ltd held APH?
Evelyn Partners Group Ltd has disclosed APH holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Evelyn Partners Group Ltd's current position in APH?
As of Q3 2026, Evelyn Partners Group Ltd holds 886.05K shares of APH (AMPHENOL CORP), valued at $74.69M, representing 1.19% of its reported portfolio and ranking #21.
Has Evelyn Partners Group Ltd been buying or selling APH?
In the latest 13F filing (Q3 2026), Evelyn Partners Group Ltd increased its position in APH. The position peaked in Q3 2026 at 886.05K shares.
Which other funds hold APH?
Other major institutional holders of APH include BlackRock Inc, Fidelity Management & Research (FMR), Capital International Investors, among 50 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.